Enquiries to the United Kingdom National Travel Advice Line by healthcare professionals regarding immunocompromised travellers

被引:5
作者
Allen, Joanna E. [1 ]
Patel, Dipti [2 ]
机构
[1] Hosp Trop Dis, London, England
[2] Natl Travel Hlth Network & Ctr, London, England
关键词
Travel medicine; immunocompromised patient; yellow fever vaccine; INTERNATIONAL TRAVEL; VACCINATION; RISKS; PATTERNS;
D O I
10.1093/jtm/taw016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. People who travel while immunocompromised are more at risk of serious travel-related infection. Their condition, medications or treatments can contraindicate, decrease the effectiveness of or increase the toxicity of vaccinations or malaria chemoprophylaxis. Therefore, immunocompromised travellers require careful assessment and specialized pre-travel advice. The aims of this study were to investigate enquiries by healthcare professionals (HCPs) to the UK National Travel Health Network and Centre (NaTHNaC) advice line regarding travellers with immunocompromise and to identify their most common concerns. Methods. Documentation for all calls taken by advisers at the London office during 2013 was reviewed. Results. Of the 4910 enquiries to the London NaTHNaC advice line, 397 calls concerned immunocompromised travellers (8.1%). The majority of immunocompromised travellers were planning to visit Sub-Saharan Africa (53%) for the purpose of tourism (43%). Sixty-seven percent of enquiries concerned vaccine use, 11% were about malaria chemoprophylaxis, 20% were about both and 2% were for other reasons. Causes of immunocompromise included inflammatory or autoimmune conditions (43%), cancer (18%), splenic dysfunction (13%), immunosuppressive drugs (12%), human immunodeficiency virus (11%), primary immunodeficiency (1%), neutropenia (0.5%) and thymus abnormalities (0.5%). Conclusions. There were frequent enquires to the advice line by UK HCPs regarding immunocompromised travellers. The travellers in this study had a wide range of underlying medical conditions and varying levels of immunocompromise. These enquiries may reflect a lack of clarity in current national guidelines, difficulties in interpreting them or both. Establishing the reasons for these deficiencies as well as the reasons behind UK HCP concerns and lack of confidence requires further investigation. This research has highlighted potential knowledge gaps and will help inform future guidance and educational activities for UK HCPs advising travellers.
引用
收藏
页数:5
相关论文
共 21 条
[1]  
[Anonymous], STAM SUMM PROD CHAR
[2]  
Barte H, 2014, COCHRANE DB SYST REV, V1, P1
[3]   International travel in the immunocompromised patient: a cross-sectional survey of travel advice in 254 consecutive patients [J].
Bialy, C. ;
Horne, K. ;
Dendle, C. ;
Kanellis, J. ;
Littlejohn, G. ;
Ratnam, I. ;
Woolley, I. .
INTERNAL MEDICINE JOURNAL, 2015, 45 (06) :618-623
[4]   Evaluation of Travel Medicine Practice by Yellow Fever Vaccination Centers in England, Wales, and Northern Ireland [J].
Boddington, Nicola L. ;
Simons, Hilary ;
Launders, Naomi ;
Gawthrop, Mary ;
Stillwell, Alexandra ;
Wong, Claire ;
Mathewson, John ;
Hill, David R. .
JOURNAL OF TRAVEL MEDICINE, 2012, 19 (02) :84-91
[5]  
Boggild AK, 2004, J TRAVEL MED, V11, P37, DOI 10.2310/7060.2004.13633
[6]  
Department of Health, 2013, IMMUNISATION INFECT
[7]   Trends and characteristics among HIV-infected and diabetic travelers seeking pre-travel advice [J].
Elfrink, Floor ;
van den Hoek, Anneke ;
Sonder, Gerard J. B. .
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2014, 12 (01) :79-83
[8]   Response to Hepatitis A Vaccination in Immunocompromised Travelers [J].
Garrido, Hannah M. Garcia ;
Wieten, Rosanne W. ;
Grobusch, Martin P. ;
Goorhuis, Abraham .
JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (03) :378-385
[9]  
Geretti AM, 2015, BHIVA GUIDELINES USE
[10]   Review Article: Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years [J].
Gotuzzo, Eduardo ;
Yactayo, Sergio ;
Cordova, Erika .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (03) :434-444